chloroquine has been researched along with B-Cell Lymphoma in 8 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahoney, E | 1 |
Maddocks, K | 1 |
Flynn, J | 1 |
Jones, J | 1 |
Cole, SL | 1 |
Zhang, X | 1 |
Byrd, JC | 1 |
Johnson, AJ | 1 |
Brocke, P | 1 |
Armandola, E | 1 |
Garbi, N | 1 |
Hämmerling, GJ | 1 |
Yu, Z | 1 |
Healy, F | 1 |
Valmori, D | 1 |
Escobar, P | 1 |
Corradin, G | 1 |
Mach, JP | 1 |
McCoy, KL | 1 |
Gainey, D | 1 |
Inman, JK | 1 |
Stutzman, R | 1 |
Yi, AK | 1 |
Krieg, AM | 1 |
Chakrabarti, D | 1 |
Ghosh, SK | 1 |
Amitay, R | 1 |
Bar-Nun, S | 1 |
Haimovich, J | 1 |
Rabinovich, E | 1 |
Shachar, I | 1 |
Koch, N | 1 |
Moldenhauer, G | 1 |
Hofmann, WJ | 1 |
Möller, P | 1 |
8 other studies available for chloroquine and B-Cell Lymphoma
Article | Year |
---|---|
Identification of endoplasmic reticulum stress-inducing agents by antagonizing autophagy: a new potential strategy for identification of anti-cancer therapeutics in B-cell malignancies.
Topics: Antineoplastic Agents; Autophagy; Biomarkers; Cells, Cultured; Chloroquine; Endoplasmic Reticulum St | 2013 |
Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Topics: Animals; Antigen Presentation; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Cell Line; Ch | 2003 |
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
Topics: Amino Acid Sequence; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; CD4-Positive T-Lym | 1994 |
Antigen presentation by B lymphoma cells. Requirements for processing of exogenous antigen internalized through transferrin receptors.
Topics: Antigen Presentation; Antigen-Presenting Cells; Cell Line; Chloroquine; Cycloheximide; Cytochrome c | 1993 |
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
Topics: Activating Transcription Factor 2; Adjuvants, Immunologic; Animals; Calcium-Calmodulin-Dependent Pro | 1998 |
Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. III. MHC class I-restricted CTL recognizes the processed form(s) of idiotype.
Topics: Animals; Antigen-Presenting Cells; Brefeldin A; Chloroquine; Cyclopentanes; Histocompatibility Antig | 1992 |
Post-translational regulation of IgM expression in B lymphocytes. Selective nonlysosomal degradation of assembled secretory IgM is temperature-dependent and occurs prior to the trans-Golgi.
Topics: Animals; B-Lymphocytes; Blotting, Northern; Chloroquine; Electrophoresis, Polyacrylamide Gel; Gene E | 1991 |
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).
Topics: Antigens, Differentiation, B-Lymphocyte; Antigens, Surface; Biological Transport; Brefeldin A; Chlor | 1991 |